Advances in Epigenetic Diagnostics and Therapeutics (Technical Insights)

Turning On New Technology and Business Opportunities

Regular Price: USD 4,950

Special Price USD 3,713

25% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,713

PAY BY INVOICE

Be the first to review this product

Epigenetics has evidenced an unparalleled growth during the past decade. A broad spectrum of applications and translation opportunities in several life sciences core markets depict the role of this discipline in medical advances. This study aims to cover the principal aspects associated with the current situation of epigenetics-related technology and its main trends and opportunities, especially associated with strategic portfolio management.

Table of Contents

Advances in Epigenetic Diagnostics and Therapeutics (Technical Insights), Epigenetic Diagnostics and TherapeuticsTechnology Penetration and RoadmappingAdvances in Epigenetic Diagnostics and Therapeutics




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.